Document Detail


Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
MedLine Citation:
PMID:  23377328     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Hydroquinone (HQ) is the benchmark prescription agent for skin lightening. However, HQ use is recently banned in Europe and in parts of Asia because of potential long-term consequences, including carcinogenesis when orally consumed. This has resulted in development of alternative skin-lightening agents with comparable efficacy to HQ, but better safety profiles. This study examined the skin-lightening ability of a topical product containing 0.5% ellagic acid and 0.1% salicylic acid and compared its efficacy with that of a prescription generic 4% HQ product. Fifty-four multiethnic subjects were randomly assigned to use the topical test formulation or generic 4% HQ twice daily for 12 weeks to evaluate product tolerability and efficacy. Under the conditions of this double-blinded clinical study, the test product demonstrated comparable tolerance and efficacy to that of a benchmark product 4% HQ, as assessed by clinical grading, physical measurement of spot size using image analysis, and questionnaire response analysis. This study suggests that this new product provided comparable skin depigmentation benefit to the benchmark product. In addition, the product appears to have better esthetics (texture, pleasantness to use, skin feel) than the 4% HQ product. J Drugs Dermatol. 2013;12(1):52-58.
Authors:
Amanda Dahl; Margarita Yatskayer; Susana Raab; Christian Oresajo
Related Documents :
20199458 - Onychomadesis: a rare side-effect of valproic acid medication?
21723078 - Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of cas...
23250808 - Evaluation of percutaneous absorption of esculetin: effect of chemical enhancers.
22860588 - Cover caption.
3424868 - The metabolism of phenol and substituted phenols in zebra fish.
10563998 - Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  12     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-02-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  52-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation usin...
Next Document:  To cut or not to cut? A review of aesthetic approaches to the facial subcutaneous cyst.